From Complexity to Clarity: Evidence Strategy at Pandemic Speed
During the COVID-19 pandemic, a period of unprecedented uncertainty and disruption, one of the leading biopharmaceutical companies wanted to develop an Integrated Evidence Generation Plan (IEGP) to identify the critical evidence gaps & corresponding studies/initiatives that advance the COVID-19 portfolio’s priorities and Real-World Evidence (RWE) needs. We were selected as the preferred partner following a […]